Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease

Clinical trial NCT00985517 · COMPLETED

Trial details

NCT number: NCT00985517
Sponsor: Sangamo Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Idiopathic Parkinson's Disease

Start date: 2009-10-29
Primary completion: 2014-11-09
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.